It has been about a month since the last earnings report for Evercore (EVR). Shares have lost about 26.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Also, Evercore ISI upgrades shares to Outperform from In-Line with a $14 price target, raised from $12, believing the market underappreciates the Hawaii Supreme Court decision that lowers the ...

Evercore ISI has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to Outperform, citing multiple upcoming catalysts that could drive the stock higher. The firm is now factoring in CTX320 and CTX310 in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Evercore ISI upgraded Hawaiian Electric (HE) to Outperform from In Line with a price target of $14, up from $12. The market underappreciates the Hawaii Supreme Court’s decision and the low ...

Evercore ISI has upgraded CRISPR Therapeutics (NASDAQ:CRSP) to outperform from in line, citing upcoming catalysts. The investment firm said it was now including the CTX320 and CTX310 in vivo ...

In a report released yesterday, Michael Binetti from Evercore ISI reiterated a Buy rating on TJX Companies (TJX – Research Report), with a price target of $142.00. The company’s shares closed ...

On Tuesday, Evercore ISI maintained a positive outlook on Domino's Pizza (NASDAQ:DPZ) shares, reiterating an Outperform rating and a $480.00 price target. Currently trading at $455.64, the stock ...

Evercore researchers noted, meanwhile, that DeepSeek's influence on artificial intelligence demand is "evolutionary rather than revolutionary." According to a business poll, while DeepSeek's cost cuts ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (BRSE:1CG) from In-Line to Outperform. There are 577 funds or institutions reporting ...

Fintel reports that on March 5, 2025, Evercore ISI Group upgraded their outlook for Hyatt Hotels (NYSE:H) from In-Line to Outperform. As of March 4, 2025, the average one-year price target for ...